Navigation Links
Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases
Date:7/24/2012

GOTHENBURG, Sweden, July 24, 2012 /PRNewswire/ --

Albireo AB (Gothenburg, Sweden; "Albireo"), a biopharmaceutical company specializing in gastroenterology, today announced that the European Medicines Agency Committee for Orphan Medicinal Products (COMP) has issued a positive opinion on an application for orphan medicinal product status for the company's lead hepatology candidate, A4250, for the treatment of:

  • Primary Biliary Cirrhosis (PBC)
  • Progressive Familial Intrahepatic Cholestasis (PFIC)
  • Alagille Syndrome

The positive opinion of the COMP has now been forwarded to the EU commission for final approval. The designation would allow Albireo ten years of marketing exclusivity in EU member countries after obtaining market authorization, as well as streamlined regulatory review processes and registration.

"We are very pleased with the EMA´s recognition of our technology with A4250 as an orphan medicinal product for the treatment of these liver diseases in Europe", said Dr. Hans Graffner, Chief Medical officer at Albireo. "This designation is an important milestone in our efforts to provide a treatment for patients with cholestatic liver diseases; a disease entity often leading to severe symptoms, liver transplantation and with reduced survival. A4250 is an inhibitor of the bile acid transport mechanism and will decrease the toxic levels of bile acids in the liver cells."

About Primary Biliary Cirrhosis (PBC)

PBC is a slowly progressive autoimmune disease of the liver, primarily affecting women; average age when symptoms start is around 40-50 years of age. It is characterized by destruction of bile ducts resulting in an increased bile acid concentration in the liver inducing inflammation and cirrhosis. There are more than 100.000 patients with PBC in Europe. Main symptoms are fatigue, severe itching and symptoms of cirrhosis. There is no cure for PBC, some thera
'/>"/>

SOURCE Albireo AB
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
3. Nephros Receives 510(k) Clearance for Hemodiafiltration System
4. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
5. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
6. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Alexza Receives Complete Response Letter for Adasuve™ NDA
9. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
10. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
11. New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... N.C. , Sept. 29, 2014   ... one of the "Best Places to Work in ... a national leader in the sales and support ... Record solutions for physicians.  TSI Healthcare has over ... the country. The program, sponsored by ...
(Date:9/29/2014)... 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a ... diseases and cholesterol gallstones, announced today that it ... Medical Ltd. (TASE: ITMR) ("Itamar Medical"), a publicly-traded ... by the U.S. Food and Drug Administration, or ...
(Date:9/29/2014)... 29, 2014 On Friday, September ... 1.02%, the Dow Jones Industrial Average finished the day ... at 1,982.85, up 0.86%. The gains were broad based ... positive. The S&P 500 Health Care Sector Index ended ... has advanced 1.10% in the last one month. Investor-Edge ...
Breaking Medicine Technology:TSI Healthcare Named One of Modern Healthcare's "Best Places to Work in Healthcare" for Third Consecutive Year 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 3Pharma Equities Technical Momentum - Provectus Biopharma, Shire, Impax Labs, Zogenix, and TherapeuticsMD 2Pharma Equities Technical Momentum - Provectus Biopharma, Shire, Impax Labs, Zogenix, and TherapeuticsMD 3Pharma Equities Technical Momentum - Provectus Biopharma, Shire, Impax Labs, Zogenix, and TherapeuticsMD 4Pharma Equities Technical Momentum - Provectus Biopharma, Shire, Impax Labs, Zogenix, and TherapeuticsMD 5
... 6, 2011 Endologix, Inc. (Nasdaq: ELGX ... announced today that John McDermott, President and Chief Executive ... of America Merrill Lynch Health Care Conference in Las ... ConferenceDate:Tuesday, May 10, 2011Time:3:40 p.m. PTAn audio Web cast ...
... N.M., May 6, 2011 Qforma, the leading provider of ... health sciences industry, announced today the appointment of Mark Spiers ... President and CEO of Wolters Kluwer Pharma Solutions. ... leader in the pharmaceutical industry, to our Board," said Kelly ...
Cached Medicine Technology:Qforma Appoints New Member to Board of Directors 2
(Date:9/29/2014)... September 30, 2014 NAPW ... Professional, as a 2014 Professional Woman of the ... for leadership in medical device consulting. As the largest, ... spanning virtually every industry and profession, the National Association ... with over 600,000 members and nearly 300 Local Chapters. ...
(Date:9/29/2014)... 30, 2014 NAPW honors ... at Heaven Sent Consultation , as a 2014 ... with this prestigious distinction for leadership in marriage and ... professional women in the country, spanning virtually every industry ... a powerfully vibrant networking community with over 600,000 members ...
(Date:9/29/2014)... NAPW honors Natalie W. ... Private Pediatrics of Palm Beach as a 2014 ... leadership in pediatrics and family care with this prestigious ... the country, spanning virtually every industry and profession, the ... vibrant networking community with over 600,000 members and nearly ...
(Date:9/29/2014)... Park Avenue Dental, a leading ... A. Sherman who has dedicated his career to providing ... announced its inclusion in the Patient Connect 365 dentist ... to private accounts so that they may manage online ... system also allows patients to request appointments, better communicate ...
(Date:9/29/2014)... Denham Springs, LA (PRWEB) September 29, 2014 ... states their mission is to provide students with ... skills and awareness necessary to enhance their own ... Alliance of Fitness Professionals also benefits the community ... research, and service focused on the professional practice ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Sandra Lee Bennett, Independent Medical Device Professional, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Carmel T. Ross, Marriage and Family Therapist at Heaven Sent Consultation, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Dr. Natalie W. Geary, Owner / President of Private Pediatrics of Palm Beach, a 2014 Professional Woman of the Year 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 3Health News:Narconon Louisiana New Life Retreat Announces Stephen Mogavero Now Certified as a Personal Trainer 2
... may contribute to the development or worsening of ... research abstract that will be presented Tuesday, June ... 25th Anniversary Meeting of the Associated Professional Sleep ... sleep in preschool-age children significantly predicted worse parent-reported ...
... , MONDAY, June 13 (HealthDay News) -- Spending on ... overall and especially among certain groups of patients, a new ... 18 and older who used glaucoma medication between 2001 and ... increased from $445 in 2001 to $557 in 2006. ...
... -- Patient-focused outcomes are emphasized in 10 updated performance ... that were released Monday by a trio of major ... for the use of individual practitioners and group practices ... with hypertension and those with stable coronary disease," Dr. ...
... at Case Western Reserve University School of Medicine have ... that contributes to chronic health problems. If they ... cells called macrophages, "We have a shot at a ... diabetes, heart disease and cancer," said Mukesh K. Jain, ...
... HealthDay Reporter , MONDAY, June 13 (HealthDay News) ... by up to 73 percent, especially when babies are exclusively ... considered the best food for infants, and studies have shown ... for both infants and their mothers. Now, there is more ...
... American Association for Cancer Research is pleased to announce ... families and caregivers won first place in the ... Colon and Rectal Surgeons. Separately, it received three additional ... Society of Professional Journalists. "We are honored ...
Cached Medicine News:Health News:Sleep loss in early childhood may contribute to the development of ADHD symptoms 2Health News:Medical Groups Update Heart, Blood Pressure Care Guidelines 2Health News:Medical Groups Update Heart, Blood Pressure Care Guidelines 3Health News:Genetic factor controls health-harming inflammation in obese 2Health News:Breast-feeding May Shield Against Sudden Infant Death Syndrome 2Health News:Breast-feeding May Shield Against Sudden Infant Death Syndrome 3Health News:AACR's CR magazine honored with 4 prestigious journalism awards 2
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
Clinical marker immunoassay kit for detection of Myoglobin....
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
Medicine Products: